While POR deficiency also involves several other metabolic pathways, the association found between ACTH and IDO enzyme activity may explain how NAD pathway is altered in both diseases. This evidence concerns the gene IDO1 and congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency.